An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
Oral administration is the most commonly used route for drug delivery owing to its cost-
effectiveness, ease of administration, and high patient compliance. However, the absorption …
effectiveness, ease of administration, and high patient compliance. However, the absorption …
Biomedical application of mesoporous silica nanoparticles as delivery systems: A biological safety perspective
The application of mesoporous silica nanoparticles (MSNs) as drug delivery systems to
deliver drugs, proteins, and genes has expanded considerably in recent years, using in vitro …
deliver drugs, proteins, and genes has expanded considerably in recent years, using in vitro …
INFOGEST static in vitro simulation of gastrointestinal food digestion
Developing a mechanistic understanding of the impact of food structure and composition on
human health has increasingly involved simulating digestion in the upper gastrointestinal …
human health has increasingly involved simulating digestion in the upper gastrointestinal …
[HTML][HTML] In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives
Lipid-based formulations (LBFs) have demonstrated a great potential in enhancing the oral
absorption of poorly water-soluble drugs. However, construction of in vitro and in vivo …
absorption of poorly water-soluble drugs. However, construction of in vitro and in vivo …
[HTML][HTML] Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction
W Ma, L Yang, L He - Journal of pharmaceutical analysis, 2018 - Elsevier
Drug-receptor interaction plays an important role in a series of biological effects, such as cell
proliferation, immune response, tumor metastasis, and drug delivery. Therefore, the …
proliferation, immune response, tumor metastasis, and drug delivery. Therefore, the …
Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: Opportunities and challenges
KE Bremmell, CA Prestidge - Drug development and industrial …, 2019 - Taylor & Francis
Porous silica-based drug delivery systems have shown considerable promise for improving
the oral delivery of poorly water-soluble drugs. More specifically, micro-and meso-porous …
the oral delivery of poorly water-soluble drugs. More specifically, micro-and meso-porous …
[HTML][HTML] Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule
LJ Henze, NJ Koehl, H Bennett-Lenane, R Holm… - European Journal of …, 2021 - Elsevier
Within preclinical research, the pig has become an important model in regulatory toxicology
and pharmacokinetics, to assess oral dosage forms and to compare different formulation …
and pharmacokinetics, to assess oral dosage forms and to compare different formulation …
The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review
LJ Henze, NJ Koehl, JP O'Shea… - Journal of pharmacy …, 2019 - academic.oup.com
Objectives In pharmaceutical drug development, preclinical tests in animal models are
essential to demonstrate whether the new drug is orally bioavailable and to gain a first …
essential to demonstrate whether the new drug is orally bioavailable and to gain a first …
Mesoporous silica nanorods for improved oral drug absorption
N Zheng, J Li, C Xu, L Xu, S Li, L Xu - Artificial Cells, Nanomedicine …, 2018 - Taylor & Francis
Mesoporous silica nanoparticles (MSNs) have been widely used in biomedical applications.
However, most studies have been limited to spherical MSNs, while non-spherical MSNs …
However, most studies have been limited to spherical MSNs, while non-spherical MSNs …
Enhanced solubility, permeability and anticancer activity of vorinostat using tailored mesoporous silica nanoparticles
Suberoylanilide hydroxamic acid (SAHA) or vorinostat (VOR) is a potent inhibitor of class I
histone deacetylases (HDACs) that is approved for the treatment of cutaneous T-cell …
histone deacetylases (HDACs) that is approved for the treatment of cutaneous T-cell …